Manulife (Manufacturers Life Insurance)’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CADX Stock Details CADX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-48,465	Closed	-$439	–	3903
2013 Q4	$439	Sell	48,465 -1,868	-4%	-$13.5K	﹤0.01%	2147
2013 Q3	$318	Sell	50,333 -1,288	-2%	-$8.19K	﹤0.01%	2296
2013 Q2	$352K	Buy	+51,621	New	+$360K	﹤0.01%	2128

Other funds holding CADX

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CADX Position: Q1 2014 in Review

Manulife (Manufacturers Life Insurance) sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 48,465 shares — an estimated $439 sold.

Manulife (Manufacturers Life Insurance) first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $352K in Q2 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

Manulife (Manufacturers Life Insurance) reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 48,465 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $439.
Manulife (Manufacturers Life Insurance) first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
Manulife (Manufacturers Life Insurance)'s CADENCE PHARMACEUTICALS, INC COM STK position peaked at $352K in Q2 2013.
3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2014, filed 13 May 2014.